Details of the Drug Reposition

General Information of This Drug (ID: DMNCBIU)

Drug Name
IC9-CAR19 T cells   DMNCBIU
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lymphoma DISN6V4S 2A80-2A86 Phase 1 [1]
B-cell lymphoma DISIH1YQ 2A86 Phase 1 [1]
Immunoproliferative disorder DISKM0P1 2B32 Phase 1 [1]
Immune System disease DISPV68Z 4A01-4B41 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03696784) Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma